Alvox Bio
Alvox Bio47About
Alvox Bio develops and operates a proprietary platform integrating advanced human-derived 3D models, including bioprinted tissues and organoids, to generate biologically relevant preclinical data for drug discovery and translational research. Their fit-for-purpose models are designed for oncology, immune-enabled, and tissue-context applications, serving partners seeking decision-grade preclinical platforms.
Technology stack
detected 2026-07-03Email
Microsoft 365
Stack
Wix
Observability
Sentry
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Alvox Bio do?
Alvox Bio develops and operates a proprietary platform integrating advanced human-derived 3D models, including bioprinted tissues and organoids, to generate biologically relevant preclinical data for drug discovery and translational research. Their fit-for-purpose models are designed for oncology, immune-enabled, and tissue-context applications, serving partners seeking decision-grade preclinical platforms.
Where is Alvox Bio headquartered?
Alvox Bio is headquartered in Cambridge, United States.
When was Alvox Bio founded?
Alvox Bio was founded in 2021.
What industry does Alvox Bio operate in?
Alvox Bio operates in Life Sciences, Biotech, Drug Discovery, Genomics, AI-Driven Protein Design, Therapeutic Antibodies.